FDA NDC Directory · JSON-LD · Markdown

Aprepitant

NDC 68001-668 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA207777
Dosage form / routeCAPSULE · ORAL
Active ingredientsAPREPITANT (125 mg/1)
Marketing started20260210
Package count1

External sources

Source: openFDA. Public-domain (CC0).